来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置首页>技术资料首页>行业动态>公司动态>Bruker公司收购液相色谱公司Michrom Bioresources 更名为Bruker-Michrom

Bruker公司收购液相色谱公司Michrom Bioresources 更名为Bruker-Michrom

Bruker2011年4月6日 10:25 点击:3007

美国布鲁克•道尔顿公司(Bruker Daltonics)


Bruker完成对Michrom的收购 更名为Bruker-Michrom


2011年2月24日,布鲁克公司宣布收购液相色谱供应商Michrom Bioresources公司,收购金额不详。据悉,该交易预计将在几个星期内完成。

  Michrom Bioresources公司位于美国加利福尼亚州奥本市,成立至今已有20年之久,主要为生命科学、化学应用领域的用户提供液相色谱仪器及其耗材配件。2010年,Michrom公司的年度营收约为300万美元。

  据了解,布鲁克公司计划保留原Michrom公司的所有员工,并且,Michrom公司的创始人和总裁Kerry Nugent先生将成为布鲁克公司液相色谱部门的高级副总裁。

  通过此次液相色谱业务的“互补性”收购,布鲁克公司成为在质谱行业拥有重要地位的一家“新”公司。之前,AB Sciex收购了Eksigent公司的液相色谱业务;赛默飞世尔科技收购了美国戴安公司。

  布鲁克公司的化学应用部门总裁Collin D'Silva先生表示:“Michrom的产品与布鲁克的质谱是‘高度互补’的。Michrom最近推出了Advance™纳升/毛细管级超高效液相色谱 (UHPLC)和第三代液质联用离子源—CaptiveSpray™捕集喷雾离子源(CSI)。该离子源是一款即插即用式离子源,能够大大提高了液质联用仪检测灵敏度、检测动态范围和分析速度,可以为蛋白质组学及其它生命科学应用领域的用户提供更为先进、优秀的解决方案。

  Michrom总裁Kerry Nugent先生希望这笔交易可以使Michrom的核心技术产品更广泛地为全球用户提供服务。“有了布鲁克完善的生产基础设施和发达的全球分销渠道,再加上Michrom在生物化学和微流体学的专利技术,我们将能够为全球用户提供更为先进的分析解决方案。我相信,Michrom公司的专利技术具有巨大的发展潜力,将逐渐满足客户们日益苛刻的要求。”

  昨天,布鲁克公司宣布,公司的第四季度营收增长了14个百分点。

 

Bruker Announces Agreement to Acquire Michrom, a Provider of Nanoflow UHPLC Systems and CaptiveSpray Sources for Proteomics

. February 2011

 

BILLERICA, Mass., Feb 24, 2011 (BUSINESS WIRE) --

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc. ('Michrom'), a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography (LC) instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets. In particular, Michrom recently has launched the novel Advance(TM) nanoflow ultra-high performance liquid chromatography (UHPLC) system and proprietary CaptiveSpray(TM) Ionization (CSI) sources for coupling to mass spectrometry (MS) in proteomics and other life-science applications.

Financial details of the transaction were not disclosed, and the closing is expected within weeks. Michrom's revenue was approximately $3 million in 2010. Bruker intends to retain all of Michrom's employees, and Michrom's founder and president, Mr. Kerry Nugent, is expected to join Bruker as 'Senior Vice President - Liquid Chromatography'.

In commenting on the agreement, Mr. Collin D'Silva, president of Bruker's Chemical & Applied Markets division, said: "Michrom's broad portfolio of novel technologies and high-performance products is highly complementary to our mass spectrometry products. In particular, Michrom's new high duty-cycle nanoflow UHPLC platform, along with their revolutionary CaptiveSpray(TM) LC-MS interface, together will provide our customers with significant gains in throughput, sensitivity and robustness for proteomics and other nano and capillary flow LC-MS applications."

Michrom's president Kerry Nugent expects the transaction to make Michrom's products more widely available to global customers seeking these key novel technologies. He commented: "With Bruker's Fremont, California manufacturing infrastructure and well-developed global distribution channels, we will be able to make greater strides to provide customers with advanced analytical solutions that embody technologies based on our expertise in biochemistry and micro-fluidics. I am very excited that the significant potential of our new technologies is now closer to being realized by more discerning customers."

About Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information, please visit www.bruker.com.

SOURCE: Bruker Corporation

Bruker
Stacey Desrochers, +1-978-663-3660, ext. 1115
Director of Investor Relations
stacey.desrochers@bruker.com

(来源: Bruker )


全年征稿 / 资讯合作

联系邮箱:kefu@labbase.net

版权与免责声明

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, //www.next-search.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。